Zhongyang Lu1, Yanchun Li1, Junfei Jin2, Xiaoming Zhang1, Yusuf A Hannun3, Yan Huang4. 1. Division of Endocrinology, Diabetes and Medical Genetics, Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA. 2. Division of Endocrinology, Diabetes and Medical Genetics, Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA; Laboratory of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541001, People's Republic of China. 3. Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA. 4. Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC 29401, USA; Division of Endocrinology, Diabetes and Medical Genetics, Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA. Electronic address: huangyan@musc.edu.
Abstract
OBJECTIVES: Increased levels of both saturated fatty acids (SFAs) and lipopolysaccharide (LPS) are associated with type 2 diabetes. However, it remains largely unknown how SFAs interact with LPS to regulate inflammatory responses in microvascular endothelial cells (MIC ECs) that are critically involved in atherosclerosis as a diabetic complication. In this study, we compared the effects of LPS, palmitic acid (PA), the most abundant saturated fatty acid, or the combination of LPS and PA on interleukin (IL)-6 expression by MIC ECs and explored the underlying mechanisms. METHODS: Human cardiac MIC ECs were treated with LPS, PA and LPS plus PA and the regulatory pathways including receptors, signal transduction, transcription and post-transcription, and sphingolipid metabolism for IL-6 expression were investigated. RESULTS: G protein-coupled receptor (GPR)40 or free fatty acid receptor 1 (FFA1), but not toll-like receptor 4, was involved in PA-stimulated IL-6 expression. PA not only stimulated IL-6 expression by itself, but also remarkably enhanced LPS-stimulated IL-6 expression via a cooperative stimulation on mitogen-activated protein kinase and nuclear factor kappa B signaling pathways, and both transcriptional and post-transcriptional activation. Furthermore, PA induced a robust neutral sphingomyelinase (nSMase)-mediated sphingomyelin hydrolysis that was involved in PA-augmented IL-6 upregulation. CONCLUSION: PA boosted inflammatory response of microvascular endothelial cells to LPS via GPR40 and nSMase. Published by Elsevier Ireland Ltd.
OBJECTIVES: Increased levels of both saturated fatty acids (SFAs) and lipopolysaccharide (LPS) are associated with type 2 diabetes. However, it remains largely unknown how SFAs interact with LPS to regulate inflammatory responses in microvascular endothelial cells (MIC ECs) that are critically involved in atherosclerosis as a diabetic complication. In this study, we compared the effects of LPS, palmitic acid (PA), the most abundant saturated fatty acid, or the combination of LPS and PA on interleukin (IL)-6 expression by MIC ECs and explored the underlying mechanisms. METHODS:Human cardiac MIC ECs were treated with LPS, PA and LPS plus PA and the regulatory pathways including receptors, signal transduction, transcription and post-transcription, and sphingolipid metabolism for IL-6 expression were investigated. RESULTS:G protein-coupled receptor (GPR)40 or free fatty acid receptor 1 (FFA1), but not toll-like receptor 4, was involved in PA-stimulated IL-6 expression. PA not only stimulated IL-6 expression by itself, but also remarkably enhanced LPS-stimulated IL-6 expression via a cooperative stimulation on mitogen-activated protein kinase and nuclear factor kappa B signaling pathways, and both transcriptional and post-transcriptional activation. Furthermore, PA induced a robust neutral sphingomyelinase (nSMase)-mediated sphingomyelin hydrolysis that was involved in PA-augmented IL-6 upregulation. CONCLUSION: PA boosted inflammatory response of microvascular endothelial cells to LPS via GPR40 and nSMase. Published by Elsevier Ireland Ltd.
Authors: Celia P Briscoe; Andrew J Peat; Stephen C McKeown; David F Corbett; Aaron S Goetz; Thomas R Littleton; David C McCoy; Terry P Kenakin; John L Andrews; Carina Ammala; James A Fornwald; Diane M Ignar; Stephen Jenkinson Journal: Br J Pharmacol Date: 2006-05-15 Impact factor: 8.739
Authors: A Haimovitz-Friedman; C Cordon-Cardo; S Bayoumy; M Garzotto; M McLoughlin; R Gallily; C K Edwards; E H Schuchman; Z Fuks; R Kolesnick Journal: J Exp Med Date: 1997-12-01 Impact factor: 14.307
Authors: Javad Habibi; Vincent G DeMarco; Jack L Hulse; Melvin R Hayden; Adam Whaley-Connell; Michael A Hill; James R Sowers; Guanghong Jia Journal: J Mol Cell Cardiol Date: 2022-03-22 Impact factor: 5.763
Authors: Anitsi Loaiza; María D Carretta; Anja Taubert; Carlos Hermosilla; María A Hidalgo; Rafael A Burgos Journal: BMC Vet Res Date: 2016-02-25 Impact factor: 2.741